Axillary Vein Cannulation: 'Hockey' Probe Versus Linear Probe

NCT06805279 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-02-03

No results posted yet for this study

Summary

Central venous catheterization, specifically through the axillary vein, is a procedure of critical importance in various clinical contexts. Site selection is dependent on clinical assessment, experience and the physician preference. This study aims to evaluate the potential advantages of using the "hockey stick" ultrasonography probe for axillary vein cannulation and determine whether this probe enhances axillary vein imaging, accelerates the central vein cannulation procedure and reduces the rate of complications compared to the linear probe. Methods: 100 participants were recruited and allocated into two groups: the linear probe group and the hockey stick probe group. All procedures were performed by two senior anesthesia and intensive care residents, each with experience of over 100 central vascular access procedures. Follow-up chest X-rays were taken two hours post-procedure to verify the correct position of the catheter and to rule out complications such as pneumothorax, hemothorax, cardiac tamponade, and incorrect line placement.

Conditions

  • CVC
  • Ultrasound Guided Central Venous Cannulation

Interventions

PROCEDURE

Axillary Vein Cannulation

This study aims to evaluate the potential advantages of using the "hockey stick" ultrasonography probe for axillary vein cannulation and determine whether this probe enhances axillary vein imaging, accelerates the central vein cannulation procedure and reduces the rate of complications compared to the linear probe

Sponsors & Collaborators

  • Medical University of Warsaw

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2024-07-01
Completion
2024-07-01

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06805279 on ClinicalTrials.gov